Breast Feeding Practice in High Risk Pregnant Women
1 other identifier
observational
140
1 country
1
Brief Summary
The American Academy of Paediatrics recognizes multiple benefits of breastfeeding to both the term and premature newborn, particularly with regard to protection from infectious agents. Studies have demonstrated decreased rates of bacteraemia, meningitis, respiratory and urinary tract infections, necrotizing enterocolitis, and otitis media among breastfed infants
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 6, 2017
CompletedFirst Posted
Study publicly available on registry
June 7, 2017
CompletedStudy Start
First participant enrolled
July 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedApril 23, 2021
April 1, 2021
3.3 years
June 6, 2017
April 22, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
The number of breast feeding women during pregnancy
6 months
Study Arms (2)
Low risk pregnant women
evaluation of the efficacy of breastfeeding Low risk pregnant women
high risk pregnant women
evaluation of the efficacy of breastfeeding high risk pregnant women
Eligibility Criteria
Patients attending Sohag general hospital
You may qualify if:
- Diabetes mellitus.
- Cardiac disease.
- Essential hypertension.
- Chronic chest disease, and/or chronic TB infection.
- Chronic hepatitis.
- Neurologic disease.
- Anaemia (Hemoglobin \<10 gm/dL).
- Thyroid disease.
- Multiple pregnancy.
You may not qualify if:
- pregnant women \< 34 weeks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut Faculty of Medicine
Asyut, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
June 6, 2017
First Posted
June 7, 2017
Study Start
July 1, 2017
Primary Completion
October 31, 2020
Study Completion
December 31, 2020
Last Updated
April 23, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share